Question

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

2 comments2

Total Forecasters39

Community Prediction81%

Make a Prediction

community: 80.8%

median 80.8%mean 80.2%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

60%

MetaculusM

🚀Metaculus Open-Source Rewrite is Live!

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Make a Prediction

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Comments

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?